
Appian Announces First Quarter 2025 Financial Results
APPIAN CORPORATION CONSOLIDATED BALANCE SHEETS (in thousands, except par value and share data) | |||||||
As of | |||||||
March 31, 2025 | December 31, 2024 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 134,982 | $ | 118,552 | |||
Short-term investments and marketable securities | 64,716 | 41,308 | |||||
Accounts receivable, net of allowance of $2,323 and $3,396, respectively | 136,037 | 195,069 | |||||
Deferred commissions, current | 34,858 | 36,630 | |||||
Prepaid expenses and other current assets | 41,309 | 43,984 | |||||
Total current assets | 411,902 | 435,543 | |||||
Property and equipment, net of accumulated depreciation of $34,326 and $32,142, respectively | 36,330 | 37,109 | |||||
Goodwill | 26,546 | 25,555 | |||||
Intangible assets, net of accumulated amortization of $5,842 and $5,341, respectively | 2,032 | 2,240 | |||||
Right-of-use assets for operating leases | 31,645 | 31,081 | |||||
Deferred commissions, net of current portion | 58,457 | 60,540 | |||||
Deferred tax assets | 4,388 | 4,129 | |||||
Other assets | 21,599 | 24,842 | |||||
Total assets | $ | 592,899 | $ | 621,039 | |||
Liabilities and Stockholders' Deficit | |||||||
Current liabilities | |||||||
Accounts payable | $ | 6,574 | $ | 4,322 | |||
Accrued expenses | 13,825 | 11,388 | |||||
Accrued compensation and related benefits | 26,487 | 34,223 | |||||
Deferred revenue | 258,582 | 281,760 | |||||
Debt | 9,598 | 9,598 | |||||
Operating lease liabilities | 12,798 | 12,378 | |||||
Other current liabilities | 2,518 | 1,087 | |||||
Total current liabilities | 330,382 | 354,756 | |||||
Long-term debt | 238,426 | 240,826 | |||||
Non-current operating lease liabilities | 51,518 | 52,189 | |||||
Deferred revenue, non-current | 3,944 | 5,477 | |||||
Other non-current liabilities | 374 | 431 | |||||
Total liabilities | 624,644 | 653,679 | |||||
Stockholders' deficit | |||||||
Class A common stock-par value $0.0001; 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024 and 43,132,115 and 42,938,701 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 4 | 4 | |||||
Class B common stock-par value $0.0001; 100,000,000 shares authorized as March 31, 2025 and December 31, 2024 and 31,088,085 and 31,090,085 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 3 | 3 | |||||
Additional paid-in capital | 597,086 | 591,281 | |||||
Accumulated other comprehensive loss | (15,507 | ) | (11,774 | ) | |||
Accumulated deficit | (613,331 | ) | (612,154 | ) | |||
Total stockholders' deficit | (31,745 | ) | (32,640 | ) | |||
Total liabilities and stockholders' deficit | $ | 592,899 | $ | 621,039 | |||
APPIAN CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) | |||||||
Three Months Ended March 31, | |||||||
2025 | 2024 | ||||||
(unaudited) | |||||||
Revenue | |||||||
Subscriptions | $ | 134,352 | $ | 117,694 | |||
Professional services | 32,074 | 32,141 | |||||
Total revenue | 166,426 | 149,835 | |||||
Cost of revenue | |||||||
Subscriptions | 14,894 | 12,270 | |||||
Professional services | 24,024 | 25,727 | |||||
Total cost of revenue | 38,918 | 37,997 | |||||
Gross profit | 127,508 | 111,838 | |||||
Operating expenses | |||||||
Sales and marketing | 54,553 | 58,156 | |||||
Research and development | 39,517 | 39,771 | |||||
General and administrative | 34,272 | 33,446 | |||||
Total operating expenses | 128,342 | 131,373 | |||||
Operating loss | (834 | ) | (19,535 | ) | |||
Other non-operating (income) expense | |||||||
Other (income) expense, net | (5,716 | ) | 8,207 | ||||
Interest expense | 5,318 | 5,646 | |||||
Total other non-operating (income) expense | (398 | ) | 13,853 | ||||
Loss before income taxes | (436 | ) | (33,388 | ) | |||
Income tax expense (benefit) | 741 | (465 | ) | ||||
Net loss | $ | (1,177 | ) | $ | (32,923 | ) | |
Net loss per share: | |||||||
Basic and diluted | $ | (0.02 | ) | $ | (0.45 | ) | |
Weighted average common shares outstanding: | |||||||
Basic and diluted | 74,094 | 73,300 | |||||
APPIAN CORPORATION STOCK-BASED COMPENSATION EXPENSE (in thousands) | |||||||
Three Months Ended March 31, | |||||||
2025 | 2024 | ||||||
(unaudited) | |||||||
Cost of revenue | |||||||
Subscriptions | $ | 243 | $ | 213 | |||
Professional services | 1,407 | 1,578 | |||||
Operating expenses | |||||||
Sales and marketing | 2,188 | 2,527 | |||||
Research and development | 2,938 | 3,001 | |||||
General and administrative | 3,263 | 3,287 | |||||
Total stock-based compensation expense | $ | 10,039 | $ | 10,606 | |||
APPIAN CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) | |||||||
Three Months Ended March 31, | |||||||
2025 | 2024 | ||||||
Cash flows from operating activities | |||||||
Net loss | $ | (1,177 | ) | $ | (32,923 | ) | |
Adjustments to reconcile net loss to net cash provided by operating activities | |||||||
Stock-based compensation | 10,039 | 10,606 | |||||
Depreciation expense and amortization of intangible assets | 2,446 | 2,361 | |||||
Bad debt expense | (125 | ) | (135 | ) | |||
Amortization of debt issuance costs | 150 | 140 | |||||
Benefit for deferred income taxes | (163 | ) | (450 | ) | |||
Foreign currency transaction (gains) losses, net | (3,989 | ) | 11,806 | ||||
Changes in assets and liabilities | - | - | |||||
Accounts receivable | 60,259 | 40,061 | |||||
Prepaid expenses and other assets | 6,107 | (2,245 | ) | ||||
Deferred commissions | 3,855 | 1,569 | |||||
Accounts payable and accrued expenses | 4,755 | 5,187 | |||||
Accrued compensation and related benefits | (9,306 | ) | (8,703 | ) | |||
Other current and non-current liabilities | 507 | 1,944 | |||||
Deferred revenue | (27,554 | ) | (10,120 | ) | |||
Operating lease assets and liabilities | (838 | ) | (232 | ) | |||
Net cash provided by operating activities | 44,966 | 18,866 | |||||
Cash flows from investing activities | |||||||
Proceeds from maturities of investments | 13,611 | 9,657 | |||||
Purchases of investments | (37,037 | ) | - | ||||
Purchases of property and equipment | (651 | ) | (2,198 | ) | |||
Net cash (used by) provided by investing activities | (24,077 | ) | 7,459 | ||||
Cash flows from financing activities | |||||||
Proceeds from borrowings | - | 50,000 | |||||
Payments for debt issuance costs | - | (463 | ) | ||||
Debt repayments | (2,500 | ) | (1,250 | ) | |||
Repurchase of common stock | - | (50,019 | ) | ||||
Payments for employee taxes related to the net share settlement of equity awards | (3,199 | ) | (2,862 | ) | |||
Proceeds from exercise of common stock options | 190 | 345 | |||||
Net cash used by financing activities | (5,509 | ) | (4,249 | ) | |||
Effect of foreign exchange rate changes on cash and cash equivalents | 1,050 | (1,319 | ) | ||||
Net increase in cash and cash equivalents | 16,430 | 20,757 | |||||
Cash and cash equivalents at beginning of period | 118,552 | 149,351 | |||||
Cash and cash equivalents at end of period | $ | 134,982 | $ | 170,108 | |||
Supplemental disclosure of cash flow information: | |||||||
Cash paid for interest | $ | 5,018 | $ | 5,325 | |||
Cash paid for income taxes | $ | 798 | $ | 751 | |||
Supplemental disclosure of non-cash financing information: | |||||||
Accrued capital expenditures | $ | 784 | $ | 484 | |||
APPIAN CORPORATION RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES (unaudited, in thousands, except per share data) | |||||||||||||||||||||||||||
GAAP Measure | Stock-Based Compensation | Litigation Expenses | JPI Amortization | Lease Impairment and Lease-Related Charges | Unrealized Foreign Exchange Gains and Losses | Non-GAAP Measure | |||||||||||||||||||||
Three Months Ended March 31, 2025 | |||||||||||||||||||||||||||
Subscriptions cost of revenue | $ | 14,894 | $ | (243 | ) | $ | - | $ | - | $ | - | $ | - | $ | 14,651 | ||||||||||||
Professional services cost of revenue | 24,024 | (1,407 | ) | - | - | - | - | 22,617 | |||||||||||||||||||
Total cost of revenue | 38,918 | (1,650 | ) | - | - | - | - | 37,268 | |||||||||||||||||||
Total operating expense | 128,342 | (8,389 | ) | (1,712 | ) | (3,084 | ) | (312 | ) | - | 114,845 | ||||||||||||||||
Operating (loss) income | (834 | ) | 10,039 | 1,712 | 3,084 | 312 | - | 14,313 | |||||||||||||||||||
Non-operating (income) expense | (5,716 | ) | - | - | - | - | 4,016 | (1,700 | ) | ||||||||||||||||||
Income tax impact of above items | 741 | 455 | - | - | - | (267 | ) | 929 | |||||||||||||||||||
Net (loss) income | (1,177 | ) | 9,584 | 1,712 | 3,084 | 312 | (3,749 | ) | 9,766 | ||||||||||||||||||
Net (loss) income per share, basic and diluted(a,b) | $ | (0.02 | ) | $ | 0.13 | $ | 0.02 | $ | 0.04 | $ | - | $ | (0.05 | ) | $ | 0.13 | |||||||||||
Three Months Ended March 31, 2024 | |||||||||||||||||||||||||||
Subscriptions cost of revenue | $ | 12,270 | $ | (213 | ) | $ | - | $ | - | $ | - | $ | - | $ | 12,057 | ||||||||||||
Professional services cost of revenue | 25,727 | (1,578 | ) | - | - | - | - | 24,149 | |||||||||||||||||||
Total cost of revenue | 37,997 | (1,791 | ) | - | - | - | - | 36,206 | |||||||||||||||||||
Total operating expense | 131,373 | (8,815 | ) | (742 | ) | (4,504 | ) | - | - | 117,312 | |||||||||||||||||
Operating (loss) income | (19,535 | ) | 10,606 | 742 | 4,504 | - | - | (3,683 | ) | ||||||||||||||||||
Non-operating expense (income) | 8,207 | - | - | - | - | (11,848 | ) | (3,641 | ) | ||||||||||||||||||
Income tax impact of above items | (465 | ) | 604 | - | - | - | 935 | 1,074 | |||||||||||||||||||
Net (loss) income | (32,923 | ) | 10,002 | 742 | 4,504 | - | 10,913 | (6,762 | ) | ||||||||||||||||||
Net (loss) income per share, basic and diluted | $ | (0.45 | ) | $ | 0.14 | $ | 0.01 | $ | 0.06 | $ | - | $ | 0.15 | $ | (0.09 | ) |
(a) Per share amounts do not foot due to rounding.
(b) Accounts for the impact of 0.4 million shares of dilutive securities.
Three Months Ended March 31, | |||||||
2025 | 2024 | ||||||
Reconciliation of adjusted EBITDA: | |||||||
GAAP net loss | $ | (1,177 | ) | $ | (32,923 | ) | |
Other (income) expense, net | (5,716 | ) | 8,207 | ||||
Interest expense | 5,318 | 5,646 | |||||
Income tax expense (benefit) | 741 | (465 | ) | ||||
Depreciation expense and amortization of intangible assets | 2,446 | 2,361 | |||||
Stock-based compensation expense | 10,039 | 10,606 | |||||
Litigation Expenses | 1,712 | 742 | |||||
JPI Amortization | 3,084 | 4,504 | |||||
Lease Impairment and Lease-Related Charges | 312 | - | |||||
Adjusted EBITDA | $ | 16,759 | $ | (1,322 | ) | ||
1


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- FXIFY Celebrates 2 Years As Industry's First And Oldest Broker-Backed Prop Firm
- B2PRIME Strengthens Institutional Team's Growth With Appointment Of Lee Shmuel Goldfarb, Formerly Of Edgewater Markets
- Pepeto To Launch On Exchange Following Presale Wrap-Up And Platform Milestones
- Falcon Finance Launches Transparency Page
- SPAYZ.Io To Roll Out Payment Solutions In Key African Markets
- BTSE Cares Foundation & Singapore Football Club Renew Winning Partnership
Comments
No comment